Journal of Clinical & Experimental Pathology
Open Access

On behalf of the Board of the Journal of Clinical and Experimental Pathology (JCEP) and my co-editors I am proud to introduce you to the first fully open access peer-reviewed online journal in cancer. The journal started publishing in 2011 and has since then published several high-quality papers and reviews. Journal of Clinical and Experimental Pathology (JCEP) is a peer-reviewed, open access journal that reflects articles on all types of Pathological disorders. Though the journal started recently it has completed 9 volumes successfully and now it is in 10^th volume. This is the result of the work of many people committed to the creation and development of a journal that focuses on standards relevant to the Clinical and pathological trails. Our goal is to provide scholars worldwide with comparative papers on recent developments and research work on Clinical and Experimental Pathological fields on the international level.

It delivers timely interpretations of key scientific developments in Clinical Pathology and its related areas of study. Known personalities with expertise and published studies in a specific field are invited to write reviews and editorials in our journal. Un- invited reviews will also be accepted if written by experts with publications in the field. Manuscripts submitted to the journal will be accepted on the understanding that the author has not previously submitted the paper to another journal or had the material published elsewhere. Manuscripts are rejected if it shows high percentage of plagiarism.

JCEP Journal is the most preferred and highly accessed Journal in the field of cancer and prevention. The Journal is indexed in Google scholar, Index Copernicus, CNKI and Scholar among many other reputed scientific databases. At many instances’ members of the editorial board also prefer to submit their articles. Such practice is common in other reputed specialty Journals. In fact, journal encourages editorial board members to actively contribute [1]. All scientific manuscripts including editorials are subjected to peer review. Journal follows a double-blind peer review process where identity of authors and reviewers is not revealed to each other. The review generally involves two to six subject experts. The editorial team consisting of associate editors and assistant editors are involved in the entire article cycle starting from submission to final recommendation. The entire review process is carefully structured so as to minimize possibility of bias [2].

I would like to extend my appreciation to members of the editorial board, who do a substantial amount of work reviewing manuscripts submitted to the journal. In addition to editorial board members, I also rely on ad hoc reviewers.

In 2020 journal aims to serves as a forum for new concepts and advances in Journal of Clinical & Experimental Pathology focuses on the areas such as coagulopathy, Thromboelastography, Immunology, virology, Hematopathology, Anatomical-pathology, leukocyteextravasation, proteoglycans, Nephropathy, heamostasis, anatomical pathology, medical methods used for pathological analysis, disease diagnosis and cure, clinical pathology, forensic pathology, physiological aspects of pathology, coagulopathy etc.

Journal of Clinical & Experimental Pathology - Open Access using online manuscript submission, review and tracking systems of OMICS Group for quality and quick review processing [3]. OMICS Group is using Online Review and Editorial Tracking Systems for quality review process. Editorial tracking System is an online submission and review system, where authors can submit manuscripts and track their progress. Reviewers can download manuscripts and submit their opinions. Editors can manage the whole submission/review/revise/publish process. Publishers can see what manuscripts are in the pipeline awaiting publication.

Our editorial policy is governed by independent quality control. It is guaranteed by the Editorial Board. We are proud to have such eminent scholars in our Editorial board which is composed of professors from world. In conclusion, I would like to thank all prominent members of our Editorial Council for joining us in this new fascinating and promising academic journal and also the reviewers for their constant support and dedication for expert review process. We are looking to expand our panel of reviewers and editorial board from across the various sub specialties in child neurology [4].

• 21day rapid review process with international peer-review standards.

• Timeline of processing from Submission to Publication is 45 days.

• Manuscript will be published within 7days of acceptance.

Useful tips have been proposed to aid effective use of the social media in promoting research and increasing visibility of the one's work.

We are happy to announce that the journal also now uses social media like Facebook, twitter, LinkedIn, blog posters, advertisements, special issue banners etc. All the articles published in our journal are posted in social media so that it may help readers and researchers globally [5].

LinkedIn: It is a professional networking platform. You can use it share updates on your research or a paper in a specific group or publicly.

Mendeley: This platform can help you grow your network by joining groups of your interest.

Research Gate: It is a social networking platform especially for scientists and researchers to share and interact on research topics. It can also be used effectively to collaborate with other researchers on a common interest area.

We look forward to work with all of you as we continue to make Journal of Clinical and Experimental Pathology a success and we welcome your submissions, as well as feedback as authors, readers, and reviewers of the journal.

I would also like to express my gratitude to all the authors, reviewers, the publisher, the advisory and the editorial board of Jcep, the office bearers and staff for their support in bringing out yet another volume of Jcep and look forward to their unrelenting support to bring out the Volume 10 of Jcep in scheduled time.